PM360

JUNE 29, 2022

However, patient uptake hasn’t matched rising market competition. But even though a majority of migraine patients are turning to their doctors for guidance, they may not be getting the most up-to-date information on available treatments. Doctor-Patient Communication, Self-Advocacy Drive Medication Uptake.

Prescription 98

Prescription Patients Pharma Doctors 98

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, Tysabri was performing well, having yielded $776 million in sales after being first approved in 2004, as per Biogen’s 2009 financial filings. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape. Biogen’s activity in multiple sclerosis.

Government 59

Government Specialization Physicians Education 59

Cadensee

JULY 20, 2021

It's become the main thing that the doctors are looking at now. When he was going through his cancer, he died in 2004. It broke the confines of you being a doctor learning healthcare, learning to be a medical profession and that stayed there; it just broke it all. Interview Transcription (mild edits). Okay, the irony?

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97